Pharmaceutical Business review

Seegene launches new diarrhea test

Based on the company’s dual priming oligo (DPO) technology, the Seeplex diarrhea ACE detection tests for 10 bacteria (Salmonella species, Shigella species, Campylobacter species, Vibrio species, C difficile Toxin B, C perfringens, Y enterocolitica, Aeromonas species, E.coli0157:H7, Verocytotoxin-producing E.coli) and four viruses (rotavirus, norovirus, enteric adenovirus, astrovirus) that cause diarrhea.

By accurately detecting and differentiating diarrhea causing viruses from bacteria, the Seeplex diarrhea ACE detection test will help healthcare practitioners apply the correct course of treatment for patients at the earliest possible stage, the company said.

Jong-Yoon Chun, founder and CEO of Seegene, said: “Taking only six hours to detect either bacterial or viral infection, Seeplex diarrhea ACE detection is an accurate, rapid and cost-effective diarrhea diagnostic tool that offers a new way for diagnosing diarrhea.”